Search Results - "Robert Orenstein"

Refine Results
  1. 1

    The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study by KHANNA, Sahil, PARDI, Darrell S, ARONSON, Scott L, KAMMER, Patricia P, ORENSTEIN, Robert, ST SAUVER, Jennifer L, SCOTT HARMSEN, W, ZINSMEISTER, Alan R

    Published in The American journal of gastroenterology (01-01-2012)
    “…Clostridium difficile infection (CDI) is a common hospital-acquired infection with increasing incidence, severity, recurrence, and associated morbidity and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile Infection by Dubberke, Erik R., Orenstein, Robert, Khanna, Sahil, Guthmueller, Beth, Lee, Christine

    Published in Infectious diseases and therapy (01-02-2023)
    “…Introduction Effective treatments for recurrent Clostridioides difficile infection (rCDI) are urgently needed. RBX2660 is an investigational microbiota-based…”
    Get full text
    Journal Article
  4. 4

    Asymptomatic Clostridium difficile colonization in a tertiary care hospital: Admission prevalence and risk factors by Leekha, Surbhi, MBBS, MPH, Aronhalt, Kimberly C., MA, RN, Sloan, Lynne M., BS, Patel, Robin, MD, Orenstein, Robert, DO

    Published in American journal of infection control (01-05-2013)
    “…Background The role of Clostridium difficile (CD) carriers in health care-associated CD transmission has been identified as an area needing research. We…”
    Get full text
    Journal Article
  5. 5

    Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility by Seto, Charlie T, Jeraldo, Patricio, Orenstein, Robert, Chia, Nicholas, DiBaise, John K

    Published in Microbiome (25-11-2014)
    “…The role of the gut microbiome in arresting pathogen colonization and growth is important for protection against Clostridium difficile infection (CDI)…”
    Get full text
    Journal Article
  6. 6

    Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection: Mayo Clinic in Arizona Experience by Patel, Neal C., MD, Griesbach, Cheryl L., RN, DiBaise, John K., MD, Orenstein, Robert, DO

    Published in Mayo Clinic proceedings (01-08-2013)
    “…Abstract Objective To report the initial experience of treating recurrent Clostridium difficile infection (CDI) with fecal microbiota transplant (FMT) at Mayo…”
    Get full text
    Journal Article
  7. 7

    An outbreak of Mycobacterium chelonae infections in tattoos by Drage, Lisa A., MD, Ecker, Phillip M., MD, Orenstein, Robert, DO, Phillips, P. Kim, MD, Edson, Randall S., MD

    “…Nontuberculous mycobacteria infections may occur after cutaneous procedures. Review of the medical records of patients who developed a rash within a tattoo…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis by Blair, Janis E, Chang, Yu-Hui H, Cheng, Meng-Ru, Vaszar, Laszlo T, Vikram, Holenarasipur R, Orenstein, Robert, Kusne, Shimon, Ho, Stanford, Seville, Maria T, Parish, James M

    Published in Emerging infectious diseases (01-06-2014)
    “…In Arizona, USA, primary pulmonary coccidioidomycosis accounts for 15%-29% of community-acquired pneumonia. To determine the evolution of symptoms and changes…”
    Get full text
    Journal Article
  10. 10

    Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp by Grant, Leah M., Orenstein, Robert

    Published in JIM - high impact case reports (2022)
    “…Recurrent vulvovaginal candidiasis is a common disorder which causes significant morbidity among women worldwide, and treatment options are limited…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Preoperative risk prediction of surgical site infection requiring hospitalization or reoperation in patients undergoing vascular surgery by Leekha, Surbhi, MBBS, MPH, Lahr, Brian D., MS, Thompson, Rodney L., MD, Sampathkumar, Priya, MD, Duncan, Audra A., MD, Orenstein, Robert, DO

    Published in Journal of vascular surgery (01-07-2016)
    “…Objective The objective of this study was to develop a surgical site infection (SSI) prediction score for risk assessment before elective vascular surgery…”
    Get full text
    Journal Article
  13. 13

    Clinical Characteristics and Outcomes of Patients With SARS-CoV-2 Reinfection by Comba, Isin Yagmur, Riestra Guiance, Irene, Corsini Campioli, Cristina, Challener, Douglas, Sampathkumar, Priya, Orenstein, Robert, Gordon, Joel, Bosch, Wendelyn, O’Horo, John C.

    “…To examine the clinical characteristics, risk of hospitalization, and mortality of patients diagnosed with severe acute respiratory syndrome coronavirus 2…”
    Get full text
    Journal Article
  14. 14

    Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009 by Olson, Timothy C, Bongartz, Tim, Crowson, Cynthia S, Roberts, Glenn D, Orenstein, Robert, Matteson, Eric L

    Published in BMC infectious diseases (23-05-2011)
    “…Patients with rheumatic diseases including rheumatoid arthritis (RA) are at increased risk for infections related to both the disease and its treatments. These…”
    Get full text
    Journal Article
  15. 15

    The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660 by Orenstein, Robert

    Published in Infectious diseases and therapy (01-01-2023)
    “…A recently published manuscript described findings from a phase 2 open label study of the microbiota-based live biotherapeutic product RBX2660 in patients with…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20